CYP26A1 and pharynx cancer: In conclusion, we demonstrated that carriers of downregulated CYP26A1 expression are susceptible to an increased risk of oral and pharyngeal cancers and the joint effects of genetic SNPs (rs2068888 (G/G) or rs4418728 (G/G)) and BQ use in oral and pharyngeal cancer patients.